To include your compound in the COVID-19 Resource Center, submit it here.

CPC-211: Filed IND to start Phase I trials

Cypros Pharmaceutical Corp. (CYPR),

Read the full 45 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE